A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose
NCT06886269
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Interventions
DRUG:
14C-VX-993
Sponsor
Vertex Pharmaceuticals Incorporated